InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,776.99
(
1.13%
)
US TECH 100
19,693.20
(
1.30%
)
Dow Jones
42,204.66
(
0.98%
)
Brent Oil
75.34
(
0.29%
)
Bitcoin
69,874.18
(
3.03%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cablejohn

Send PM Follow Ignore
Followers 34
Posts 3178
Boards Moderated 0
Alias Born 10/20/2012

cablejohn

Re: None

Thursday, 12/05/2013 7:17:41 PM

Thursday, December 05, 2013 7:17:41 PM

Post# of 20775
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
This study is currently recruiting participants.
Verified December 2013 by ViroPharma
Sponsor:
ViroPharma
Information provided by (Responsible Party):
ViroPharma
ClinicalTrials.gov Identifier:
NCT01898884
First received: July 3, 2013
Last updated: December 2, 2013
Last verified: December 2013
History of Changes
LINK:
http://clinicaltrials.gov/ct2/show/NCT01898884?term=VP+20629&rank=1

Any other company and this would qualify as news!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up